Hernia Mesh Devices Market

Hernia Mesh Devices Market

Growth Factors of Hernia Mesh Devices Market

The hernia mesh devices market size was valued at USD 2.19 billion in 2023, and the market is now projected to grow from USD 2.29 billion in 2024 to USD 3.76 billion by 2032, exhibiting a CAGR of 6.4% during the forecast period of 2024-2032.

During the pandemic, the worldwide hernia mesh gadgets market fell in value. Non-emergency approaches have been postponed to avoid clinic overcrowding and virus transmission. Lower product demand and supply chain disruption brought about sales declines for marketplace players.

Hernia prevalence is increasing globally, with 38.8% of individuals experiencing it. This is better in overweight or obese individuals. Hernia repair surgical procedures also are growing, with a 120,000 in the UK and 1.0 million within the US annually. Abdominal hernia surgeries account for 15%-18% of world surgeries. Most hernia methods use hernia mesh devices, with 8.0% of surgeries using those gadgets. This increase in hernia surgical treatment call for is fueling the worldwide hernia mesh devices market growth.

Hernias have become more not unusual, main to extended call for hernia mesh. Market participants are prioritizing technical developments in their goods to meet growing demand.

Comprehensive Analysis of Hernia Mesh Devices Market

The marketplace for hernia mesh gadgets is segmented into biological mesh and artificial mesh. Biological mesh, which includes Phasix, is anticipated to grow at a massive CAGR due to its mechanical strength and reduced recurrence charge for incisional hernia. Synthetic mesh, however, is expected to develop at a large CAGR due to its value-effectiveness and decrease hazard of adverse occasions. The market is in addition divided into inguinal, femoral, ventral, and others. The inguinal segment is expected to grow at a substantial CAGR due to the high number of inguinal hernia repairs performed. The end-user segment is dominated by hospitals and acute care centers (ASCs), with hospitals performing around 100,000 hernia repair surgeries annually and 3 out of every four using mesh. The specialty clinics segment is also expected to grow at a significant CAGR due to increasing awareness of the efficiency of mesh procedures.

The North America region lead the hernia mesh devices market share by benefitting a market size of USD 0.77 billion in 2023 due to increased awareness and the presence of major companies including Baxter, B. Braun SE, and Medtronic.

In 2023, Medtronic, BD, and COOK held a vast international hernia mesh devices market share due to their attention on mergers and acquisitions. Medtronic teamed with virtual healthcare carrier issuer La Poste in October 2023 to expand its operations. Other players include Baxter, Integra LifeSciences, and W. L. Gore & Associates, Inc.

In December 2022, W. L. Gore and Associates, Inc. Collaborated with AGC Biologics on protein-based purification technology to reduce the manufacturing footprint and medical manufacturing costs.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 6.4% from 2024-2032

Unit Value (USD billion)

Segmentation By Product

- Biological Mesh

- Synthetic Mesh

By Type

- Inguinal

- Femoral

- Ventral

- Others

By End-user

- Hospitals & ASCs

- Specialty Clinics

- Others

By Region

- North America (by Product, by Type, by End-user, and by Country)

• U.S.
• Canada

- Europe (by Product, by Type, by End-user, and by Country/Sub-region)

• U.K.
• Germany
• France
• Spain
• Italy
• Scandinavia
• Rest of Europe

- Asia Pacific (by Product, by Type, by End-user, and by Country/Sub-region)

• Japan
• China
• Australia
• India
• Southeast Asia
• Rest of Asia Pacific

- Rest of the World (by Product, by Type, and by End-user)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.